Embed Size (px)
Citation preview
2015 AACR Annual Meeting Minisymposia Chairpersons
Sunday, April 19, 3:15pm- 5:15pm
Signaling of the Microenvironment Regulates Tumor Progression
Dr. Kornelia PolyakProfessor of MedicineDana-Farber Cancer Inst.450 Brookline Ave.Dana-740CBoston, MA 02215(617) 632-2106(617) [email protected]
Dr. Peter S. NelsonProfessor, Div. of Human BiologyFred Hutchinson Cancer Research Ctr.Mailstop D4-1001100 Fairview AvenueMailstop D4-100Seattle, WA 98109(206) 667-3377(206) [email protected]
Cancer Stem Cells 1
Dr. Andreas TrumppProfessor and Head, Div. of Stem Cells and CancerGerman Cancer Research Ctr. and HI-STEMIm Neuenheimer Feld 280Dept. A010/Hi-Stem gGmbHD-69120 HeidelbergGERMANY+49 (6221) 423-901+49 (6221) [email protected]
Dr. Catriona H. M. JamiesonAssociate Professor, Div. of Hematology/Oncology; Director for Stem Cell ResUCSD Moores Cancer Ctr.No. 08203855 Health Sciences Dr.La Jolla, CA 92093-0820(858) 534-7128(858) [email protected]
Cancer Genomics: Characterization, Evolution, and Function
Dr. Christoph LengauerChief Scientific OfficerBlueprint Medicines215 First StreetCambridge, MA 02142(617) [email protected]
Dr. Hiroyuki AburataniProfessor, Genome Science Div.The Univ. of Tokyo, RCASTRes. Ctr. for Adv. Science And Technolog4-6-1 Komaba, Meguro-KuTokyo 153-8904JAPAN+81 (3) 5452-5352+81 (3) [email protected]
MYC Family Deregulation and Targeting
Dr. David Dominguez-SolaAssistant ProfessorMt. Sinai HospitalHess CSM Building Floor 5, Room 1111470 Madison AvenueNew York, NY [email protected]
Dr. Carla GrandoriHuman BiologyFred Hutchinson Cancer Research Ctr.1100 Fairview N.C1-015Seattle, WA 98109(206) 667-1835(206) [email protected]
Oncogenic Signaling and Cell Death
Dr. Alex TokerProfessor, Dept. of PathologyBeth Israel Deaconess Medical Ctr.330 Brookline Ave., CLS-633ABoston, MA 02215(617) 794-0340(617) [email protected]
Dr. Anthony G. LetaiAssociate ProfessorDana-Farber Cancer Inst.450 Brookline AvenueMayer 429Boston, MA 02215(617) 632-2348(617) [email protected]
Cell Cycle Mechanisms of Anticancer Drug Action
Dr. Geoffrey I. ShapiroAssociate Professor of Medicine, Dept. of Medical OncologyDana-Farber Cancer Inst.Mayer 446450 Brookline Ave.Boston, MA 02215(617) 632-4942(617) [email protected]
Dr. Helen M. Piwnica-WormsVice Provost, ScienceUT MD Anderson Cancer Ctr.1515 Holcombe Blvd.Unit 1492Houston, TX 77030(713) [email protected]
New Carcinogenic Mechanisms Revealed by Gastrointestinal Tract Cancer
Dr. S. Perwez HussainInvestigator, Lab. of Human Carcinogen.National Cancer Inst.Building 37, Room 3044B37 Convent Dr.Bethesda, MD 20892-4255(301) 402-3431(301) [email protected]
Dr. Yinling HuNCI-FrederickBldg. 567, Room 252Frederick, MD 21701(301) 846-1478(301) [email protected]
Biomarkers and Cancer: New Insights
Dr. Sonja BerndtOEEBNCI-DCEG6120 Executive Blvd.EPS 8116Bethesda, MD 20892(301) 594-7898(301) [email protected]
Dr. Meira EppleinAssistant ProfessorVanderbilt Univ. Medical Ctr.Division of Epidemiology2525 West End Ave., 6th Fl.Nashville, TN 37203(615) 936-2145(615) [email protected]
Liquid Biopsies
Dr. Jorge S. Reis-FilhoAttending Pathologist, Dept. of PathologyMem. Sloan Kettering Cancer Ctr.Dept. of Pathology1275 York AveNew York, NY 10065(212) 639-8054(212) [email protected]
Caroline DiveClinical & Experimental Pharmacology GrpCRUK Manchester InstituteWilmslow Rd.Manchester M20 4BXENGLAND+44 (161) 446-3036+44 (161) [email protected]
Drug Discovery: New Targets and Antibody Drug Conjugates
Dr. Elizabeth A. HarringtonDirector, Translational ScienceAstraZeneca plcAstraZeneca310 Milton RoadCambridgeshire CB4 0WGENGLAND+44 (0)7557 [email protected]
Dr. Klaus BossletHead Discovery Oncology PenzbergRoche Diagnostics GmbHNonnenwald 2B. 231 / R. 56282377 PenzbergGERMANY+49 (0) 8856 60-6668+49 (0) 8856 [email protected]
Late-Breaking Minisymposium
Dr. Judy LiebermanProfessor of PediatricsHarvard Medical SchoolImmune Disease Inst.200 Longwood Ave., WAB 255Boston, MA 02115(617) 713-8600(617) [email protected]
Dr. William C. HahnChief, Division of Molecular and Cellular OncologyDana-Farber Cancer Inst.Dana 1538450 Brookline Ave.Boston, MA 02215(617) 632-2641(617) [email protected]
Monday, April 20, 3:00pm- 5:00pm
Epigenetic and Metabolic Regulation in the Microenvironment
Dr. Irene M. GhobrialAssistant Professor, Dept. of Medical Onc.Dana-Farber Cancer Inst.450 Brookline AveHIM 240Boston, MA 02115(617) 632-4198(617) [email protected]
Dr. Aldo M. RoccaroMedical OncologyDana-Farber Cancer Inst.Dana-Farber Cancer Institute450 Brookline AvenueHIM Building H246Boston, MA 02215(617) [email protected]
Mouse Models of Human Cancer 2
Dr. Lewis A. ChodoshChair, Dept. of Cancer BiologyUniv. of Pennsylvania612 BRB II/III421 Curie Blvd.Philadelphia, PA 19104(215) 898-1321(215) [email protected]
Dr. Anton Jm BernsSenior Group Leader, Div. of Molecular GeneticsNetherlands Cancer Inst.Plesmanlaan 121Amsterdam 1066 CXNETHERLANDS+31 (20) 512-1991+31 (20) [email protected]
Mechanisms of Cancer Initiation and New Targets for Prevention
Dr. Cory Abate-ShenProfessor of UrologyColumbia Univ. Irving Comp. Cancer Ctr.Room 321B1130 St. Nicholas Ave.New York, NY 10032(212) [email protected]
Dr. Andrew J. DannenbergProfessor of MedicineWeill Medical College of Cornell University1300 York Ave.Room F-206New York, NY 10021(212) 746-4403(212) [email protected]
Non-Coding RNAs in Cancer Biology 2
Dr. Erwei SongProfessor, Breast Tumor Ctr.Sun Yat-sen Memorial Hospital107 Yanjiang West Rd.510120 GUANGZHOUCHINA+86 (20) 8133-2603+86 (20) [email protected]
Dr. Joshua MendellProfessor, Molecular BiologyUT Southwestern Medical Center5323 Harry Hines Blvd. Dallas, TX 75390-9148214-648-5183(214) [email protected]
Cancer Epigenetics
Dr. Feyruz V. RassoolAssoc. Professor, Dept. of Radiation Onc.Univ. of Maryland School of Medicine655 W. Baltimore St.BRB 7-023Baltimore, MD 21201(410) 706-5337(410) [email protected]
Dr. James M. FlanaganSenior Lecturer, Dept. of Surgery & CancerImperial College London64 Thornhill RdLondon E10 5LLENGLAND+44 (20) 7594-2127+44 (20) [email protected]
Immune Checkpoint Inhibition
Dr. Mario SznolProfessor, Medical OncologyYale Cancer Ctr.333 Cedar St.FMP 126, P.O. Box 208032New Haven, CT 06520-8032(203) 737-2572(203) [email protected]
Dr. Jeffrey A. SosmanProfessor of MedicineVanderbilt Univ. Medical Ctr.Preston Research Building 7772220 Pierce Ave.Nashville, TN 37232(615) 322-4967(615) [email protected]
Molecular Mechanisms of Sensitivity or Resistance to Pathway – Targeted Agents
Dr. Paul WorkmanCEO and PresidentThe Institute of Cancer ResearchHaddow LaboratoriesCancer Therapeutics Unit15 Cotswold Rd.London SM2 5NGENGLAND+44 (20) 8722-4301+44 (20) [email protected]
Dr. Richard M. MaraisDirector, Cancer Research UK Manchester Inst.Cancer Research UK Manchester InstituteWilmslow RoadManchester M20 4BXENGLAND+44(0)161 446 3101+ 44 (161) [email protected]
PARP and DNA Repair Inhibitors
Dr. Yves G. PommierChief, Developmental Therapeutics BranchNCI-CCR37 Convent Dr.Building 37, Room 5068Bethesda, MD 20892-4255(301) 496-5944(301) [email protected]
Dr. Malcolm A. SmithAssoc. Branch Chief, PediatricsNational Cancer Inst.Cancer Therapy Evaluation Prog.RM 5-W414, MSC 97379609 Medical Center Dr.Bethesda, MD 20892(240) 276-6087(240) [email protected]
Predictive and Prognostic Biomarkers
Dr. Steven D. AverbuchVP, Translational Clinical Development & PharmacodiagnosticsBristol-Myers Squibb Co.RandD, Room J.14-01P.O. Box 4000Princeton, NJ 08543(609) 252-5820(609) [email protected]
Dr. Laura J. van 't VeerProfessor, Dept. of Laboratory MedicineUCSF Helen Diller Family Comp. Cancer Ctr.UCSF Box 08082340 Sutter St. N-415San Francisco, CA 94143-0808(415) 476-6023(415) [email protected]
Progress toward New Drugs and New Drug Technologies
Dr. Matthew A. MarxPrincipalMarx Pharma Consulting, LLC10231 Lone Dove StreetSan Diego, CA 92127(858) [email protected]
Dr. Katerina LeftherisSr. Director, Cancer ChemistryCelgene Corp.10719 Passerine WaySan Diego, CA 92121(858) [email protected]
Tuesday, April 21, 3:00pm- 5:00pm
Clonal Evolution, Epithelial-Mesenchymal Transition, and Metastatic Colonization
Dr. Filippo G. GiancottiProfessor, Cell Biology Prog.Mem. Sloan Kettering Cancer Ctr.Building RRL, Room 401A, Box 2161275 York Ave.New York, NY 10065-6304(212) 639-8694(212) [email protected]
Dr. Sandra S. McAllisterAsst. Professor/Assoc. ScientistHarvard Medical SchoolBrigham and Women's HospitalKarp Research Bldg. 05.2141 Blackfan Cir., 5th Fl.Boston, MA 02115(617) 355-9059(617) [email protected]
Metabolism and Cancer 3
Dr. Chi Van DangDirectorAbramson Cancer Ctr. of Univ. of Penn.Penn Tower, Suite 1600399th S. 34th StreetPhiladelphia, PA 19104(215) [email protected]
Dr. Valeria R. FantinVP, Tumor Cell Biology, OncologyPfizer, Inc.10724 Science Center Dr.San Diego, CA 92121(858) [email protected]
Targeting Signaling Pathways in Cancer
Dr. Lloyd C. TrotmanAssistant ProfessorCold Spring Harbor LaboratoryJames Lab Building, P.O. Box 100One Bungtown Rd.Cold Spring Harbor, NY 11724(516) 367-5054(516) [email protected]
Dr. Jean J. ZhaoAssociate Professor, Biological Chemistry and Molecular PharmacologyDana-Farber Cancer Institute and Harvard Medical School450 Brookline AveSmith 936ABoston, MA 02215(617) 632-2932(617) [email protected]
Adoptive Immunotherapy
Dr. Nabil M. AhmedAsst. Professor, Dept. of PediatricsBaylor College of MedicineFeigin Suite, 17701102 Bates St.Houston, TX 77025(832) 824-4611(832) [email protected]
Dr. Michael C. JensenSeattle Children's Hospital1100 Olive Waysuite 100Seattle, WA 98101(206) [email protected]
Molecular Endocrinology of Breast and Prostate Cancer
Dr. Lesley-Ann MartinGroup Leader, Molec. EndocrinologyToby Robins Cancer Research Ctr.Inst. Of Cancer Research237, Fulham Rd.London SW3 6JBENGLAND+44 (207) 153-5329+44 (207) [email protected]
Dr. Myles A. BrownDirector, Ctr. for Functional Cancer EpigeneticsDana-Farber Cancer Inst.Harvard Medical School450 Brookline Ave.DANA-0730Boston, MA 02215(617) 632-3948(617) [email protected]
Refined Targeting of the PI3K Pathway in Cancer
Dr. Phillip A. DennisVP, Disease Strategy Head, Lung CancerAstraZenecaGlobal Medicines DevelopmentOne Medimmune WayBldg. 200 ORD, #1206FGaithersburg, MD [email protected]
Dr. David Alexander FrumanProfessor, Molec. Bio. & Biochem.UC Irvine3242 McGaugh HallZot 3900Irvine, CA 92697(949) 824-1947(949) [email protected]
Exploiting the MAPK Pathway in Cancer
Dr. S. Gail EckhardtProfessor/Medicine/OncologyUniv. of Colorado Cancer Ctr.12801 E. 17th Ave.L18-8111Campus Box 8117Aurora, CO 80045-2539(303) 724-3850(303) [email protected]
Dr. Alex A. AdjeiChairman, Dept. of MedicineRoswell Park Cancer Inst.Elm and Carlton Sts.Buffalo, NY 14263(716) 845-4101(716) [email protected]
Molecular and Genetic Epidemiology of Cancer 4: New Insights
Dr. Fredrick R. SchumacherAsst. Professor, Dept. of Preventive Med.USC/Norris Comprehensive Cancer Ctr.HNRT/ Room 2504, MC 96011450 Biggy St.Los Angeles, CA 90033-9601(323) 442-7882(323) [email protected]
Dr. Brandon L. PierceAsst. Professor, Dept. of Health StudiesUniv. of Chicago5841 S. Maryland Ave., MC2007Billings Bldg., Rm. N101Chicago, IL 60637(773) 703-1917(773) [email protected]
Precision Medicine in the Clinic
Dr. Pasi A. JänneAssociate Professor of MedicineDana-Farber Cancer Inst.450 Brookline Ave. HIM 223Boston, MA 02215(617) 632-6036(617) [email protected]
Dr. David B. SolitGeoffrey Beene Chair, Director, Center of Molecular OncologyMem. Sloan Kettering Cancer Ctr.1275 York Ave.New York, NY 10065(646) [email protected]
Pediatric Cancer: Basic Science 3
Dr. A. Thomas LookVice Chair for Research, Pediatric Onc. Dept.Dana-Farber Cancer Inst.Mayer 630450 Brookline Ave.Boston, MA 02215(617) 632-5826(617) [email protected]
Dr. Rani E. GeorgeAssociate Professor, Dept. of Pediatric Onc.Dana-Farber Cancer Inst.Dana-Farber Cancer Institute450 Brookline AvenueDana 640EBoston, MA 02215(617) 632-5281(617) [email protected]
